Immunovant, Inc. IMVT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Immunovant, Inc.’s reported figures.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s free cash flow?
- Immunovant, Inc. (IMVT) reported free cash flow of -$95.07M in Q1 2026.
- How has Immunovant, Inc.'s free cash flow changed year-over-year?
- Immunovant, Inc.'s free cash flow increased by 14.2% year-over-year, from -$110.84M to -$95.07M.
- What is the long-term trend for Immunovant, Inc.'s free cash flow?
- Over 4 years (2022 to 2026), Immunovant, Inc.'s free cash flow has grown at a 39.9% compound annual growth rate (CAGR), from -$106.37M to -$407.32M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.